ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Excellent — I now have a strong set of confirmed US earnings events for the week. I have enough to write the article.

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Excellent — I now have a strong set of confirmed US earnings events for the week. I have enough to write the article.

Big Week Ahead: Gilead, Marriott, EA Report

Today (Friday, May 1) opens with Encompass Health and Lear Corporation both holding Q1 earnings calls this morning. Mohawk Industries follows at midday.

Monday, May 4 brings Corebridge Financial and BioMarin Pharmaceutical, with BioMarin's $10B biotech reporting after the close.

Tuesday, May 5 is the busiest day. Electronic Arts — a $51B gaming giant — reports Q4 results. IDEXX Laboratories holds its earnings call at 8:30am. Neurocrine Biosciences and Cytokinetics add biotech weight to the session.

Wednesday, May 6 features Marriott International, the $94B hotel group. Cencora — a $61B pharma distributor — also reports. Flex Ltd. and BorgWarner round out a busy mid-week slate.

Thursday, May 7 closes the week with the heavyweights. Gilead Sciences — a $160B biopharma — delivers Q1 results after the close. Microchip Technology and Akamai Technologies both report that evening. Insmed and Corpay add further depth.

No significant IPOs are scheduled in the US this week. The earnings calendar alone keeps investors busy, with healthcare and tech dominating the schedule.

How this article was generated

Generated
1 May 2026, 08:32
Prompt version
migrated
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.